Michelle T. Long MD, MSc
Associate Professor, Preventive Medicine & Epidemiology
Associate Professor, Gastroenterology
85 E. Concord St | (617) 638-8392michelle.long@bmc.org
mtlong@bu.edu
Sections
Preventive Medicine & Epidemiology
Gastroenterology
Centers
Framingham Heart Study
Boston Nutrition Obesity Research Center
Evans Center for Interdisciplinary Biomedical Research
Biography
Michelle T. Long, MD, MSc is a physician-scientist with an expertise in Nonalcoholic fatty liver disease (NAFLD), and an Associate Professor of Medicine at Boston University. She completed her clinical training at Massachusetts General Hospital and Boston Medical Center. Dr. Long is the Director of the NAFLD Research Center and the Director of Clinical Research for the Section of Gastroenterology and Hepatology. Her clinical and research interests center on the relationship between NAFLD and cardiovascular disease. Dr. Long is primarily interested in patient-oriented research investigating fibrosis and inflammation in patients with NAFLD and in imaging and risk stratification strategies for hepatic fibrosis. Dr. Long has projects at Boston Medical Center and at the Framingham Heart Study where she is the PI of a study evaluating the prevalence and risk factors for liver fat (steatosis) and fibrosis. In Framingham, she is investigating the clinical and genetic correlates of hepatic steatosis and fibrosis as measured by transient elastography. Dr. Long receives research funding from the NIH (NIDDK), Doris Duke Charitable Foundation, Gilead Sciences, Echosens Corporation, and Boston University. She has expertise in epidemiology, visceral fat, liver imaging including computed tomography, ultrasound, and transient elastography. Dr. Long is also a clinical hepatologist and endoscopist.
Dr. Long is additionally interested in novel therapeutics for NAFLD and Non-alcoholic steatohepatitis (NASH) and runs the clinical trials program for the NAFLD Research Center.
Her other research interests include alcohol-related liver disease, hepatitis C, outcomes in end-stage liver disease/cirrhosis.
Education
Medicine-Internal, MD, Tufts University School of Medicine
Epidemiology, MSc, Boston University School of Public Health
Neuroscience/Neurology, BA, Middlebury College
Publications
Florea VV, Gajjar P, Huang S, Tang J, Zhao S, Davenport M, Mi MY, Haff M, Zhang X, Miller PE, Vasan RS, Liu CT, Lewis GD, Shah RV, Long MT, Nayor M. Hepatic Steatosis and Fibrosis, Cardiorespiratory Fitness, and Metabolic Mediators in the Community. Liver Int. 2025 Jan; 45(1):e16147. PMID: 39673712.
Published on 10/16/2024Yiannakou I, Long MT, Jacques PF, Beiser A, Pickering RT, Moore LL. Eggs, Dietary Choline, and Nonalcoholic Fatty Liver Disease in the Framingham Heart Study. J Nutr. 2024 Oct 16. PMID: 39424072.
Published on 6/14/2024Alanaeme CJ, Ghazi L, Akinyelure OP, Wen Y, Christenson A, Poudel B, Dooley EE, Chen L, Hardy ST, Foti K, Bowling CB, Long MT, Colantonio LD, Muntner P. Trends in the Prevalence of Multiple Chronic Conditions Among US Adults With Hypertension From 1999-2000 Through 2017-2020. Am J Hypertens. 2024 Jun 14; 37(7):493-502. PMID: 38576398.
Published on 6/9/2024Sun N, Prescott B, Ma J, Mohanty A, Long MT, Walker ME. Prevalence of Steatotic Liver Disease Subtypes and Association With Metabolic Risk Factors in the Framingham Heart Study. Clin Gastroenterol Hepatol. 2024 Nov; 22(11):2330-2333. PMID: 38857746.
Published on 5/29/2024Niezen S, Goyes D, Vipani A, Yang JD, Ayoub WS, Kuo A, Long MT, Trivedi HD. Food Insecurity in Hispanic Populations Is Associated with an Increased Risk of Hepatic Steatosis: A Nationally Representative Study. J Clin Med. 2024 May 29; 13(11). PMID: 38892917.
Published on 5/16/2024Cooper LL, Prescott BR, Xanthakis V, Benjamin EJ, Vasan RS, Hamburg NM, Long MT, Mitchell GF. Association of Aortic Stiffness and Pressure Pulsatility With Noninvasive Estimates of Hepatic Steatosis and Fibrosis: The Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2024 Jul; 44(7):1704-1715. PMID: 38752348.
Published on 1/5/2024Fantasia KL, Austad K, Mohanty A, Long MT, Walkey A, Drainoni ML. Safety-Net Primary Care and Endocrinology Clinicians' Knowledge and Perspectives on Screening for Nonalcoholic Fatty Liver Disease: A Mixed-Methods Evaluation. Endocr Pract. 2024 Mar; 30(3):270-277. PMID: 38184239.
Published on 12/6/2023Altajar S, Wang N, Rosenthaler MP, Murabito JM, Long MT. NAFLD Associates with Sarcopenia Defined by Muscle Mass and Slow Walking Speed: A Cross-Sectional Analysis from the Framingham Heart Study. J Clin Med. 2023 Dec 06; 12(24). PMID: 38137592.
Published on 11/17/2023Dichtel LE, Corey KE, Haines MS, Chicote ML, Lee H, Kimball A, Colling C, Simon TG, Long MT, Husseini J, Bredella MA, Miller KK. Growth Hormone Administration Improves Nonalcoholic Fatty Liver Disease in Overweight/Obesity: A Randomized Trial. J Clin Endocrinol Metab. 2023 Nov 17; 108(12):e1542-e1550. PMID: 37379033.
Published on 11/17/2023Donovan K, Thomas OW, Sweeney T, Ryan TJ, Kytomaa S, Zhao M, Zhong W, Long M, Rajendran I, Sarfaty S, Lenders C. Eat to Treat: The Methods and Assessments of a Culinary Medicine Seminar for Future Physicians and Practicing Clinicians. Nutrients. 2023 Nov 17; 15(22). PMID: 38004212.
Media Mentions
Published on 8/4/2023
Is Fatty Liver Disease a Risk Factor for Cardiovascular Disease?
Published on 12/20/2022
Even Non-heavy Drinking May Lead to Liver Problems, Says New Study
Published on 12/20/2022
Even Non-heavy Drinking May Lead to Liver Problems, Says New Study
Published on 12/8/2022
Study finds non-heavy alcohol use associated with liver fibrosis
Published on 8/30/2022
Not the Usual Suspects: Don't Overlook NAFLD in Lean Patients
Published on 7/26/2022
New Update Focuses on NAFLD in Lean People
Published on 7/26/2022
New update focuses on NAFLD in lean people
Published on 6/27/2022
Mixed Bag for Semaglutide in NASH-Related Compensated Cirrhosis
Published on 5/9/2022
Fatigue Tied to Worse Outcomes in Patients With NASH
Published on 4/13/2022
Adding Mesalamine to Corticosteroids Showed No Benefit in Patients With Severe UC
View full list of 26 media mentions.